Calcium Channel Blocker Market
Calcium Channel Blocker Market Size, Share & Trends Analysis Report
Calcium Channel Blocker Market Size, Share, Statistics & Trends Analysis Report By Drug Class (Dihydropyridine, Benzothizepine, Phenylalkylamine) By End User (Hospitals, Homecare, Specialty Clinics) By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) Based On Region, And Segment Forecasts, 2024 – 2030
Published
Report ID : BMRC 2982
Number of pages : 300
Published Date : Jun 2024
Category : Healthcare
Delivery Timeline : 48 hrs
Key Players
- Bausch Health (Canada)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd (Israel)
- Sun Pharmaceutical Industries Ltd (India)
- Novartis AG (U.S.)
- Zydus Group (India)
- Pfizer Inc (U.S.)
- Lupin (India)
- GSK Plc (U.K.
- Sofgen (U.S.)
- Glenmark Pharmaceuticals Inc (India)
- Amneal Pharmaceuticals (U.S.)
- Covis Pharma GmbH (Switzerland)
Segmentation
Drug Class
- Dihydropyridine
- Benzothizepine
- Phenylalkylamine
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
SUMMARY
Segments
Segmentation
Drug Class
- Dihydropyridine
- Benzothizepine
- Phenylalkylamine
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- Bausch Health (Canada)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd (Israel)
- Sun Pharmaceutical Industries Ltd (India)
- Novartis AG (U.S.)
- Zydus Group (India)
- Pfizer Inc (U.S.)
- Lupin (India)
- GSK Plc (U.K.
- Sofgen (U.S.)
- Glenmark Pharmaceuticals Inc (India)
- Amneal Pharmaceuticals (U.S.)
- Covis Pharma GmbH (Switzerland)
